Cell Therapy & Gene Therapy Equipment calculator
Cell Therapy Batch Failure Cost Calculator
Batch Failure Cost helps quality, MSAT, and operations leaders put a cost number on contamination, viability failure, vector failure, documentation rejection, or other batch loss scenarios. It combines planned batch count, cost per batch, expected failure rate, and fixed investigation or remediation cost.
What this calculator does
- Estimate expected financial exposure from failed, contaminated, or unreleased cell therapy and gene therapy batches.
- a quality or operations team is estimating the cost impact of expected batch failures in a GMP production plan
- The result estimates expected cost exposure from batch failures for the selected product, suite, or campaign period.
Formula used
- Variable failed-batch loss = planned GMP batches × direct cost per failed batch × expected batch failure rate
- Expected batch failure cost = variable failed-batch loss + fixed deviation or remediation cost
Inputs explained
- Planned GMP batches at risk: Count patient batches, donor lots, vector runs, or drug product batches in the planning period.
- Direct cost per failed batch: Include materials, labor, suite time, QC testing, vector, single-use kits, and disposal cost that would be lost.
- Expected batch failure rate: Use historical failure, contamination, unreleased-batch, or campaign risk data for the same process maturity.
- Fixed deviation or remediation cost: Add one-time costs such as investigation labor, CAPA execution, repeat validation, expedited testing, or patient rescheduling.
How to use the result
- Use it during risk reviews, capacity planning, cost-per-patient modeling, and investment cases for closed processing or contamination controls.
- It does not value patient impact, schedule delay, regulatory impact, or lost revenue unless those amounts are included in the cost inputs.
Common questions
- What counts as a failed batch? Use the definition that matches your process: contamination, sterility failure, low viability, failed vector transduction, out-of-spec release test, chain-of-identity issue, or batch record rejection.
- Should patient rescheduling cost be included? Include it in either direct cost per failed batch or fixed remediation cost if it is part of your financial exposure model.
- How should I set the failure rate? Use recent process-specific history when available; otherwise use a conservative estimate from similar products, maturity stage, or risk assessment.
- What decision can I make from the result? Use it to justify process improvements, closed-system investments, added training, supplier changes, or additional capacity buffer.
Last reviewed 2026-05-12.